Erlotinib hydrochloride
Drug timelines are a Plus or Pro feature.
38 regulatory and trial events tracked for Erlotinib hydrochloride, covering 2013-05-20 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]